In honor of Pain Awareness Month, the U.S. Pain Foundation and the Alliance to Advance Comprehensive Integrative Pain...
federal advocacy Articles
Advocacy round-up
What better way to honor Pain Awareness Month than taking action at the federal level? Here are a few opportunities to...
U.S. Pain joins CBD coalition
The U.S. Pain Foundation recently has been participating in the Collaborative for CBD Science & Safety (CCSS),...
U.S. Pain spearheads joint letter to Congress from 30 patient and professional groups
U.S. Pain Foundation recently spearheaded a joint letter to the U.S. House Energy and Commerce (E&C) Committee and...
Hearing on medical cannabis important progress; take action to ask for second hearing
On Jan. 15, the House Energy and Commerce Subcommittee on Health held a hearing on discrepancies between state and...
Summary of FDA listening session on osteoarthritis now available
Last August, U.S. Pain Foundation arranged for three patient representatives and one caregiver to speak about the...
Your advocacy made a difference in CMS’s recent decision!
This week, Centers for Medicare & Medicaid Services (CMS) shared it will cover acupuncture for chronic low back...
Advocates continue to push for hearing on pain management best practices
As 2019 comes to a close, advocates are making a final push for Congress to hold a hearing on the Pain Management Best...
Want to encourage medical cannabis research at the federal level?
A new federal bill would expand and coordinate scientific research of cannabidiol (CBD) or marijuana-derived products,...
Chronic Pain Patients Pinpoint the Need for Improved Methods to Assess Pain
New York, NY – Nov. 21, 2019 – The US Pain Collaborative, comprised of advocacy leaders from across the pain...
Read U.S. Pain’s letter to the FDA
U.S. Pain Foundation was among several hundred organizations and individuals to weigh in on a recent Food and Drug...
How should the FDA evaluate new medications for pain?
We wanted to make you aware of an opportunity to submit public comments to the Food and Drug Administration (FDA)....